Concepedia

Gar-Yang Chau

GC

Statistics

Publications

34

Citations

4.1K

H-Index

23

Active since

1992

Affiliations

Taipei Veterans General Hospital(Current)

National Yang Ming Chiao Tung University

National Yang Ming University Hospital

National Taiwan University

Gar-Yang Chau is an author at Taipei Veterans General Hospital specializing in medicine, oncology, and hepatocellular carcinoma.

Publications per year

1992–2021

34

Publications

34

Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial

Jordi Bruix, Tadatoshi Takayama, Vincenzo Mazzaferro et al. · The Lancet Oncology · 2015 · 1.1K citations

, , +17

Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trial

Riccardo Lencioni, Josep M. Llovet, Guohong Han et al. · Journal of Hepatology · 2016 · 692 citations · Full text

, , +5

Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma #

Muh‐Hwa Yang, Chih-Li Chen, Gar-Yang Chau et al. · Hepatology · 2009 · 356 citations · Full text

, , +12

Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial

Roser Pinyol, Robert Montal, Laia Bassaganyas et al. · Gut · 2018 · 335 citations · Full text

, , +17

Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis

Teh‐Ia Huo, Jaw‐Ching Wu, Pui-Ching Lee et al. · Hepatology · 1998 · 253 citations · Full text

, , +16

1–5 of 34